CDXS vs VRTX: Which Stock is Better?
Side-by-side comparison of Codexis Inc and Vertex Pharmaceuticals Inc in 2026
CDXS
Codexis Inc
$2.59
VRTX
Vertex Pharmaceuticals Inc
$441.20
Key Metrics Comparison
| Metric | CDXS | VRTX | Winner |
|---|---|---|---|
| Market Cap | $230.81M | $110.81B | VRTX |
| P/E Ratio | N/A | 28.42 | VRTX |
| EPS (TTM) | $N/A | $15.33 | VRTX |
| Revenue Growth | 0.8% | 0.1% | CDXS |
| Gross Margin | 12.4% | 53.7% | VRTX |
Analyze CDXS
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CDXS or VRTX a better investment?
Comparing CDXS and VRTX: Codexis Inc has a market cap of $230.81M while Vertex Pharmaceuticals Inc has $110.81B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CDXS and VRTX?
CDXS (Codexis Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CDXS or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CDXS or VRTX?
CDXS has higher revenue growth at 0.8% vs 0.1% for VRTX.
Which company is more profitable: CDXS or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 12.4% for CDXS.
Which is the larger company: CDXS or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $110.81B compared to $230.81M for CDXS.
Should I buy CDXS or VRTX in 2026?
Both CDXS and VRTX have investment merit. CDXS trades at $2.59 while VRTX trades at $441.20. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CDXS and VRTX stock?
Key differences: Market Cap ($230.81M vs $110.81B), P/E Ratio (N/A vs 28.4x), Revenue Growth (0.8% vs 0.1%), Gross Margin (12.4% vs 53.7%).